TAG:
lab service
More Crime, More Consolidation, and a New Threat
By R. Lewis Dark | From the Volume XII No. 6 – April 18, 2005 Issue
IT’S A SHAME THAT OUR LEAD STORY IN THIS ISSUE IS CRIMINAL INDICTMENTS of six former IMPATH executives. It is a black mark on the lab industry and is just one more factor that makes it tougher for honest laboratorians to successfully lobby Congress on adequate funding for laborator…
LabCorp Buys Esoterix For $150 Million in Cash
By Robert Michel | From the Volume XII No. 6 – April 18, 2005 Issue
CEO SUMMARY: Laboratory Corporation of America continues to display an appetite to grow by acquisition. However, its purchase of Esoterix, Inc. creates unique management problems for LabCorp, because Esoterix is itself a product of a lab acquisition strategy. Over the past ten years, Esot…
FL Medicaid Gives Up On Statewide Lab Contract
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: With the withdrawal of the December 13, 2004 “Invitation to Negotiate” (ITN), Florida’s Medicaid bureaucrats seem to have thrown in the towel—at least for the moment—on the effort to give a single laboratory company an exclusive three-year contract to provide labora…
Review of 2004 Lab Sales Identifies Buyer Interest
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
CEO SUMMARY: Laboratory acquisition activity was surprisingly high during 2004. One reason is that new buyers appeared in the marketplace. However, all buyers have specific acquisition criteria. When a selling lab meets that criteria, it can expect multiple bidders and a strong purchase p…
Florida Medicaid Contract Is On-Again, Off-Again
By Robert Michel | From the Volume XII No. 1 – January 3, 2005 Issue
CEO SUMMARY: Start with a flawed idea: Medicaid lab testing costs in Florida can be cut by awarding an exclusive statewide contract to one laboratory company. Compound that bad idea by designing a contract awards process that guarantees the state will pay twice for a number of tests while…
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
CA, FL, BC Move Forward With Lab Test Contracts
By Robert Michel | From the Volume XI No. 16 – November 22, 2004 Issue
CEO SUMMARY: Medicaid agencies in the bellwether states of California and Florida continue to push ahead with plans to revise laboratory test contract policies. In British Columbia, private laboratory companies face an uncertain future as the provincial health administration maneuvers to …
Hospital Labs Produce Moderate Cost Increases
By R. Lewis Dark | From the Volume XI No. 14 – October 11, 2004 Issue
ALL PATHOLOGISTS AND HOSPITAL LAB ADMINISTRATORS who feel beat up about endless budget cuts should take heart. During the period 2000-2002, the cost of laboratory services in hospitals increased by 18%. That is something to brag about—and here’s why! The lab services cost increase was less than …
Memphis Path Lab JV Purchased By AEL
By Robert Michel | From the Volume XI No. 14 – October 11, 2004 Issue
CEO SUMMARY: Memphis Pathology Labs’ two hospital owners and their JV partner, MDS, surprised many with the sale of the lab venture to American Esoteric Laboratories (AEL). It’s the end of a successful joint venture between several hospitals and a commercial laboratory company. It als…
Going, Going, Soon Gone: MDS Pulling Out of U.S.
By Robert Michel | From the Volume XI No. 14 – October 11, 2004 Issue
CEO SUMMARY: Even as the best of its lab testing joint ventures with hospitals and health systems prove profitable, MDS Diagnostic Services is taking active steps to resolve its participation as a partner. In a candid interview, its President and CEO acknowledged the best attributes of su…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized